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1) Only 42% of screened individuals entered the study, and 31% had sufficient parameters to be analyzed. Although you show numbers in Figure 1 , please comment on the large number of excluded subjects. Doesn't this affect the usefulness of the screening in clinical practice?
Thanks. As you have noted, of those that were screened (n =420), a large number of participants were excluded (58%). However, it should be noted that these were excluded due to ethical reasons of conducting the research as stipulated to us by the ethics committee (e.g. patients unable to provide consent (incapacity) for the research study (n=98), or that the research should not interfere with routine care of the patient and in those who had already began treatment (n = 88)), or because participants declined to take part (n = 54). We have now included this information at the start of the results sections, along with percentages of those excluded (lines 197-199) . In terms of the application of the usefulness in clinical practice, the reasons outlined above do not preclude the usefulness of the measures in the current study being used in clinical practice (i.e. in all patients admitted to hospital).
In light of this being a proof of concept study for saliva indices, we did in this instance exclude participants who had potential confounding effects on saliva (e.g. oral trauma, recent dental surgery, swallowing problems etc), although it should be noted that only 2 participants were excluded for this (both had swallowing problems), and in light of your excellent point, we have now added this information to the results (lines 198-199,) and Figure 1 , and have also now acknowledged in the discussion that future studies should investigate whether saliva indices have utility, in patients with oral related problems (please see lines 341-344). Thanks.
2) "and allowing for an approximate one-third exclusion rate from data analysis (due to missing reference tests, and co-morbidities that preclude the use of the reference standards), a total of 178 participants were recruited into the study." It appears that the exclusion rate was higher than anticipated? Please comment.
Please note that the allowance for the one third exclusion rate (for missing reference tests and comorbidities that affected the reference standards), was for those who might be excluded from the data analysis after they were already recruited into the study (i.e. n = 178 recruited). The N for which we analyzed data was n = 130, with 48 excluded from the data analysis. The proportion excluded from analysis of those recruited (48/178, 27%) is therefore actually lower, not higher than the anticipated 1/3 exclusion rate. Thanks.
3) "participants with a history of renal disease (n = 24), or who were in cardiac failure (n = 1) were excluded from data analysis." Please specify the criteria for renal disease and cardiac failure. What level of renal disease (stage?) or creatinine or other. For CHF, only "history" or other criteria? As you point out, the presence of renal disease, starvation, malnutrition (among others) limit the usefulness of the BUN/Cr ratio. It would be useful to discuss the level of renal disease that you excluded.
Thanks. For this study, we excluded from data analysis, all participants who had any known previous history of renal disease (CKD stage 1-5) or if they were in cardiac failure as diagnosed by the clinician. We have now clarified this and added this information to the methods section (Line 165).
In line with comment 1 above, we have also now added a sentence to the discussion where we discuss how future studies should investigate the utility of these indices in these relatively small populations (lines 318-320). Thanks.
4) Please discuss relationship between saliva and blood osmolality. If the values are generally highly correlated, is there any benefit in using saliva rather than blood. Is it quicker, cheaper, easier to use saliva. Given a paucity of saliva in 25% of subjects, should blood be favored?
This is a very helpful observation and the changes we have made (described below) in response have improved the take home message of the manuscript. Many thanks.
As we have addressed in the manuscript (lines 55-61, 169-171 and in Figure 1 ), plasma osmolality is elevated in, and will only detect water-loss dehydration. In water-and-solute loss dehydration, plasma osmolality is either normal or low, and thus has no diagnostic utility for this type of dehydration. Given the differential response of plasma osmolality to these two types of dehydration, we feel it would be inappropriate to report, or rely on the correlation between saliva and plasma osmolality to determine saliva's utility as a diagnostic method. In the current study, saliva osmolality was able to detect a proportion of patients with water-and-solute dehydration (sensitivity 78%), and is an easier to perform and non-invasive so has advantages over blood sampling.
With this in mind, based on your excellent point , as this limitation of plasma (blood) osmolality for detecting water-and-solute-loss only dehydration was not as prominent as it should be in the manuscript, we have now added a sentence to the end of the abstract (lines 29-31) and to the discussion and conclusion where we address this (lines 312-314, 351-352).
We were able to collect a quantity of saliva in 126/130 patients (97%)-reported on lines 210 and 328, although as we have stated (lines 213, 327) we only had adequate saliva (at least 25ul) to assess osmolality using our osmometer in 75% of samples. However, we have addressed this limitation in the discussion, (line 327-333) where we say that micro osmometers are in development that can assess P<0.001) to distinguish both dehydration types (70% sensitivity, 68% specificity, OR =5.0 (95%CI 1.7-15.1) 23 for water-loss dehydration, and 78% sensitivity, 72% specificity, OR =8.9 (95%CI 2.5-30.7) for water-and-24 solute-loss dehydration). Conclusions: With the exception of low systolic blood pressure, which could aid 25 in the specific diagnosis of water-and-solute-loss dehydration, physical signs and urine markers show little 26 utility to determine if an elderly patient is dehydrated. Saliva osmolality demonstrated superior diagnostic 27 accuracy compared with physical signs and urine markers, and may have utility for the assessment of both 28
water-loss and water-and-solute-loss dehydration in older individuals. It is particularly noteworthy that saliva 29 *Manuscript Click here to view linked References osmolality was able to detect water-and-solute-loss dehydration, for which a measurement of plasma 30 osmolality would have no diagnostic utility. 31
INTRODUCTION 33 34
Dehydration in older adults is a significant clinical problem. A diagnosis of dehydration is associated with 35 the presence of co-morbidities, longer hospital stay, additional future hospitalization and higher mortality 36 rates [1] [2] [3] [4] [5] . The point-prevalence of dehydration in community-dwelling older adults in the USA was reported 37
as 17-28% 6;7
. In many cases, simple and inexpensive oral rehydration is sufficient to treat dehydration and 38 halt the progress of more serious fluid-deficit related illnesses such as acute kidney injury. However, upon 39 hospitalization, many patients may be denied the correct course of treatment due to physician misdiagnosis 40 of dehydration 7 . Therefore, accurate and early identification of dehydration in older adults admitted to 41 hospital is vital to alleviate ill-health and the significant economic burden of treating dehydration on 42 , and/or urinary parameters 16 . 51
Nevertheless, these screening methods are often characterized by poor diagnostic performance 11;17-21 . To 52 confound hydration assessment further, the term "dehydration" is poorly defined and is used to characterize 53 many water and solute deficits relating to whole body fluid deficits 7 . In order to simplify clinical practice 54 researchers have suggested the classification of clinical dehydration into two distinct types. Firstly, water-55 loss dehydration (also termed hypertonic hypovolemia, or intracellular dehydration), which is hypertonic in 56 nature and occurs when water loss proportionally exceeds solute loss. Water loss dehydration is typically 57 defined as a plasma osmolality ≥295mOsm/kg 12;22 . Secondly, water-and-solute-loss dehydration (also 58 termed intravascular volume depletion or extracellular dehydration), which may be isotonic or hypotonic due 59 to equal, or greater proportional loss of solutes than water 10;12;23 , and typically defined as a BUN:Cr ≥20 in 60 the absence of hypertonicity 22 . To the best of our knowledge, there are few 18;19 , rigorous studies that have 61 investigated the diagnostic accuracy of clinical physical signs and/or urine indices to detect dehydration in 62 hospitalized older adults using a criterion reference method, and none which have simultaneously assessed 63 the utility of any hydration marker to assess both types of dehydration. 64
65
In a series of studies (in young healthy adults) we have shown that rapid measurements made from non-66 invasive collection of saliva fluid can be used to identify water-loss dehydration [24] [25] [26] . For example, 67 decreases in whole saliva flow rate and increases in whole saliva osmolality were shown to track progressive 68 modest dehydration (equivalent to 1-3% body mass loss). The utility of these novel saliva markers of 69 dehydration has not yet been examined in a clinical, older adult population, although encouragingly, the 70 presence of a dry tongue was identified as the clinical sign most strongly associated with dehydration in an 71 elderly cohort 14 . To this end, the purpose of this prospective study was to determine, and compare, the 72 diagnostic accuracy of clinical physical signs routinely used in hospital settings 11;13;14 , along with saliva 73 (flow rate and osmolality) and urine indices (color and specific gravity) 27 , to detect static (one-point in time) 74 water-loss, and water-and-solute-loss dehydration in a hospitalized, older adult cohort using primary 75 reference standards; plasma osmolality and BUN:Cr 10;12;22;28 . 76
77

METHODS
79
Experimental design and procedures 80
The study was conducted as a prospective, hospital-based cross-sectional study. All measures of hydration 81 status were performed within 30 minutes of admission, with no disruption to routine care in the following 82 order; examination of physical signs of dehydration, collection of saliva, blood and urine. For the reference 83 standards of whole body hydration assessment, a blood sample was collected by the clinical research fellow 84 or a specialist phlebotomist and analyzed for plasma osmolality (within 15min) and BUN:Cr (within 2h). 85
For consistency, all physical examinations and assessment of confidential medical information was carried 86 out by the same clinical research fellow (a junior doctor with five years clinical experience), who was 87 blinded to the results of the reference standards and the saliva and urine index test results when conducting 88 the physical examination. Saliva and urine samples were collected, and analyzed by an independent research 89 assistant who had been trained in the handling and assessment of saliva and urine samples by a postdoctoral 90 researcher, and who was blinded to the physical examination results. All osmolality analyses were made by 91 a trained research assistant. Details of the patients" medical condition, history and medication were recorded 92 retrospectively after the reference and index test results had been established. 93
94
Participants 95
A convenience sample of adults over 60 years of age admitted consecutively to the acute medical care unit or 96 emergency department of Gwynedd Hospital, Bangor, UK, with any primary diagnosis and capacity to 97 consent were enrolled between May and November 2011 during the times the investigators were available 98 (09:00h -17:00h, Monday-Friday). Participant exclusion criteria included: oral trauma or dental surgery 99 within 14 days, swallowing problems, salivary gland tumors, if they were deemed too unwell by the medical 100 staff to participate in the study, if they were assessed as not having capacity to consent, or if they had already 101 
Reference standards 109
Blood sample collection and analysis 110
Blood samples were collected from an antecubital or dorsal metacarpal vein without venestasis into one 111 serum separation vacutainer, and one lithium heparin coated vacutainer (Becton Dickinson, Oxford, UK). 112
Serum blood urea nitrogen and serum creatinine were assessed at the hospital clinical biochemistry 113 department using an automated biochemistry analyzer (Olympus AU 2700 chemistry immuno analyzer, 114
Beckman Coulter, USA). The lithium heparin treated blood was centrifuged immediately upon collection at 115 1500 g for 10 minutes at 4 °C. The plasma was aspirated and triplicate measurements of osmolality were 116 made immediately using a freezing point depression osmometer (Model 330 MO, Advanced Instruments, 117
Massachusetts, USA). Standard control solutions (290 mOsm/kg) were run through the osmometer and 118 checked daily to ensure acceptable limits of precision (±2 mOsm/kg). The analytical coefficient of variation 119 for repeated sample plasma osmolality measurements was 0.7% (1.9 mOsm/kg). 120
121
Index tests 122
Clinical assessment of physical signs of dehydration 123
The clinical assessment consisted of seven physical signs of dehydration that are routinely used in Gwynedd 124
Hospital; tachycardia (resting heart rate >100 beats per minute), low resting systolic blood pressure 125 (<100mmHg), dry mucous membrane (inside of the cheek, dry vs. wet), axillary dryness (assessed by 126 palpating the armpit, dry vs. moist), poor skin turgor (measured by pinching the skin on the dorsum of the 127 hand and observing if the tissue fold returned to normal immediately), presence of sunken eyes as assessed 128
by the clinical research fellow, and long capillary refill time (> 2s, assessed by holding the patients hand at 129 heart level and blanching the participant's right index finger using moderate pressure and assessing the length 130 of time for the return of normal color). Each physical sign was assessed with the participant rested and 131 seated upright and assessed dichotomously. 132
133
Saliva sample collection and analysis 134
Unstimulated whole saliva samples were collected using a pre-weighed Versi-sal® collection device (Oasis 135 Technology, USA) as previously described 29 . Participants firstly swallowed in order to empty the mouth of 136 residual saliva, before saliva was collected by placing the Versi-sal® collection device under the tongue. 137
Saliva collection was performed with minimal orofacial movements and accurately timed. After 4 min, the 138 collection device was inspected for volume of saliva by weighing it immediately (to the nearest milligram) 139 and subtracting the pre-weight. If the volume was insufficient for osmolality analysis (< 25µl), the swab was 140 replaced under the tongue for a further 4 min. By assuming the density of saliva to be 1.00g/ml, saliva flow 141 rate (SFR) was calculated by dividing the volume collected by the time of collection 24 . Saliva was 142 recovered from the collection device by centrifugation at 1500 g for 10 min, and assessed immediately in 143 duplicate for saliva osmolality using a freezing point depression osmometer (Model 330 MO, Advanced 144 Instruments, Massachusetts, USA). The analytical coefficient of variation for repeated sample saliva 145 osmolality measurements was 0.8% (0.9 mOsm/kg). 146 147
Urine sample collection and analysis 148
A mid-flow urine sample was collected and immediately analyzed for urine color 27 and urine specific 149 gravity (USG) using a handheld refractometer (Atago URC-Osmo refractometer, Japan). 150
151
Sample size calculation and data analysis 152
The desired sample size for dehydrated participants (n = 20 water-loss only) was calculated using the 153 following equation: 154
Where p = desired sensitivity (70%) as a proportion, and x = desired confidence interval (20%) as a 159
proportion 30 . Assuming a prevalence of impending water-loss dehydration (plasma osmolality ≥ 160 295mOsm/kg) of 17% 7 , and allowing for an approximate one-third exclusion rate from data analysis (due to 161 missing reference tests, and co-morbidities that preclude the use of the reference standards), a total of 178 162 participants were recruited into the study. Medical records for participants were accessed after enrolment, 163 and due to potential influencing effects on the reference standards assessed in this study, participants with a 164 history of renal disease (CKD stage 1-5, n = 24), or who were in cardiac failure as diagnosed by a clinician 165 (n = 1) were excluded from data analysis. Participants were also excluded from data analysis if the reference 166 tests were not available (n = 11), if they had an abnormally low (<10) BUN:Cr which may be indicative of 167 renal disease or the syndrome of inappropriate antidiuretic hormone (n = 8), or if they were taking 168 glucocorticoid medication (n = 4) which affects the validity of the BUN:Cr 10 . Based on the reference 169 standards, participants with a presenting plasma osmolality ≥295mOsm/kg were classified as having 170 impending water-loss dehydration 12;22 . Of the remaining participants, those with a BUN:Cr ≥20 in the 171 absence of hypertonicity 22 were classified as having water-and-solute-loss dehydration, and the remaining 172 participants formed the euhydrated control group (normal plasma osmolality and BUN:Cr). 173
174
To assess the diagnostic accuracy of saliva and urine indices, and clinical physical signs for assessment of 175 hydration status, both water-loss, and water-and-solute-loss dehydration groups were separately compared 176 with the euhydrated control group. Both dehydration groups were also combined to form a generic 177 dehydration group for comparison with euhydration. For all dichotomized clinical physical sign data, the 178 following were calculated; area under the receiver operating characteristic curve (AUC ROC ) as a measure of 179 global diagnostic accuracy, sensitivity, specificity, positive and negative likelihood ratios (LR), and the 180 diagnostic odds ratio (OR) generated by logistical regression. For continuous variable data (urine color, 181 USG, SFR and saliva osmolality), the degree to which each variable could discriminate between dehydration 182 and euhydration was assessed using AUC ROC . For variables that could distinguish hydration status, the 183 single cut-off value that provided the optimal discrimination was identified as the point on the curve with the 184 largest vertical displacement from the reference line, and sensitivity, specificity, overall diagnostic accuracy, 185 positive and negative LR, and the diagnostic OR were calculated. For all diagnostic analyses 95% 186 confidence intervals were constructed. To compare AUC ROC , a method was adopted that accounts for the 187 correlation between samples from the same individual 31 . Group data were analyzed using one-way ANOVA. 
Participant characteristics 196
A total of 420 participants were screened for inclusion, with 242 excluded, largely due to ethical 197 considerations of conducting the research, or declining to take part (n = 240, 57%), or due to swallowing 198 problems (n = 2, 1%). Therefore, 178 participants were enrolled into the study (n = 85 males, n = 93 199 females) with mean age (SD) 78 (9) y. After further exclusions for data analysis, data were analyzed for n = 200 130 participants (n = 59 males, n = 71 females; mean age 78 (9), range 60-101y), of which n = 27 (21%) 201
were classified as water-loss dehydrated, n = 25 (19%) were classified as water-and-solute-loss dehydrated, 202
and n = 78 (60%) were classified as euhydrated. Of the 27 participants in the water-loss only dehydration 203 group, 10 also had an elevated BUN:Cr (≥20). There were no differences between the groups for age ( 
Feasibility of collecting index tests 209
All clinical physical sign assessments were conducted in all 130 participants. Saliva was collected in all but 210 four participants (1 water-loss dehydrated, 2 water-and-solute-loss dehydrated, and 1 euhydrated control). 211
For these four participants SFR was recorded as zero, and SFR data was therefore analyzed for n = 130. 212
There was adequate saliva (> 25µl) to assess saliva osmolality in 98 participants (75%)
Diagnostic accuracy of clinical physical signs 218
Diagnostic data for all seven clinical physical signs for both types of dehydration are shown in Table 2 and 219 There were no differences between any of the three groups for urine color, USG or SFR ( Table 1) . 230
Furthermore, when assessed using ROC analyses, neither urine color, USG or SFR were able to discriminate 231 between dehydration and euhydration (AUC ROC range 0.49-0.57, all P > 0.05, Table 3 ). Saliva osmolality 232 was greater in participants with both forms of dehydration than euhydrated control (P < 0.001, Table 1 ), but 233 more importantly, was able to distinguish both types of dehydration separately from euhydration (AUC ROC = 234 0.76, P < 0.01 for both types of dehydration individually and combined, Table 3 ). Based on the ROC 235 analysis, the saliva osmolality cut-off that provided the optimum balance between sensitivity and specificity 236 was calculated as: 95, 97, and 94 mOsm/kg for water-loss only, water-and-solute-loss only, and both forms 237 of dehydration combined, respectively. The diagnostic accuracy of saliva osmolality to detect all 238 dehydration types is displayed in Table 4 . Saliva osmolality was able to identify water-loss dehydration, 239
water-and-solute-loss dehydration, and both forms of dehydration combined with a sensitivity of 70, 78 and 240 76%, and specificity of 68, 72, and 68%, respectively. Importantly, when AUC ROC curves were compared, 241 the ability of saliva osmolality to discriminate hydration status was superior (P < 0.05) to all clinical physical 242 signs and urine indices for both types of dehydration in older adults (Figure 2) . 243 ***Insert Table 3 and Table 4 . This prospective study sought to investigate the diagnostic accuracy of 250 routinely used clinical physical signs and urine indices, and novel, simple, non-invasive saliva indices. The 251 main finding was that currently used clinical physical signs were not able to discriminate between 252 dehydration and euhydration, and thus provide little help to the physician making an initial hydration 253 assessment. The exception was a low systolic blood pressure which could aid in the specific diagnosis of 254 water-and-solute-loss dehydration. Whilst showing promise in young healthy cohorts 27 , urine analysis 255 demonstrated no utility in identifying dehydration in an older adult cohort admitted to hospital. However, 256 the novel finding from the study was that saliva osmolality could discriminate between dehydration and 257 euhydration, and importantly, was sensitive to both water-loss, and water-and-solute-loss forms of 258 dehydration, demonstrating superior diagnostic accuracy than urinary parameters and currently used clinical 259 physical signs. Saliva collection is non-invasive, and easy to collect, and therefore, may have practical 260 utility as an initial screening method for impending dehydration in older adults. 
277
A particular strength of the current study was that both forms of dehydration were characterized 278 simultaneously using valid biochemical assessments as reference standards, including the preferred direct 279 measurement of plasma osmolality as opposed to calculated osmolality 12;37 . We observed that no clinical 280 physical sign could discriminate between either type of dehydration and euhydration when assessed using 281 AUC ROC , and thus, should not be used in isolation to diagnose hydration status in older adults admitted to 282 hospital. However, although not sensitive (16%), a low (<100mmHg) sitting systolic blood pressure, may 283 aid the physician in making a diagnosis of water-and-solute-loss dehydration owing to its very high 284 specificity (i.e. low false positive rate), high diagnostic odds ratio (OR =14.7), and high positive likelihood 285 ratio (OR =12.5). This finding is in line with the well-known effects of a loss of extracellular fluid 286 (intravascular volume depletion) on blood pressure responses. Although researchers have previously focused 287 on orthostatic blood pressure responses to assess hydration 13;15 , altering posture may be impractical in a 288 clinical setting, particularly in bed-ridden patients. Therefore, a sitting blood pressure assessment may have 289 practical value for the clinician. 290
Urinary markers have been reported as valid methods to assess acute changes in hydration status in young 292 healthy people 27 . In the current study, neither USG nor urine color were able to discriminate between 293 dehydration and euhydration. This is likely due in part, to the decreased renal function that is characteristic 294 of older age, and to a potential confounding effect on urine of the many types of medications that an older 295 adult cohort are likely to be prescribed. In support, previous studies have also shown that urine indices are 296 poor markers of hydration status in elderly patients 13;19 , in critically ill patients 20 and in young children with 297 gastroenteritis 38 . Urine collection is not always possible when required, and was only able to be collected in 298 65% of participants in the current study, and in only 79% of elderly patients in a recent clinical study 13 . 299
Taken together, we do not recommend the use of USG or urine color as screening tools for dehydration in 300 older adults. 301
302
To the best of our knowledge, this is the first study that has investigated the diagnostic accuracy of saliva 303 indices to assess dehydration in older adults admitted to hospital. Saliva sample collection is simple and 304 non-invasive and has previously been shown to track modest water-loss dehydration in young healthy males 305 [24] [25] [26] . Saliva flow rate was not associated with either form of dehydration, but the novel finding of the current 306 study was that saliva osmolality was able to detect both forms of dehydration with sensitivity >70% and 307 diagnostic OR >5. Although a sensitivity to detect dehydration of 72-78% may only be described as "fair to 308 moderate" 39 , it is important to stress that any novel diagnostic marker should be compared against what is 309 currently used in clinical practice, and in the case of the present study, a high saliva osmolality 310 (>94mOsm/kg) was able to detect more cases of both types of dehydration than any single clinical physical 311 sign or urinary marker without compromising specificity (Figure 2) . It is also worth re-iterating that saliva 312 osmolality was able to detect water-and-solute-loss dehydration, for which a measurement of plasma 313 osmolality would have no diagnostic utility. Furthermore, the cohort in the current study reflects a 314 representative, older adult clinical population, admitted with any primary diagnosis, and we did not remove 315 participants taking medications (except for 4 patients taking glucocorticoid medications). Thus, the fact that 316 a single marker is able to achieve a sensitivity > 70% for both types of dehydration at one-point in time 317 regardless of medication is promising. It remains unknown whether saliva osmolality can also identify both 318 types of dehydration in the relatively small proportion of patients in this study taking glucocorticoid 319 medication, in patients with heart failure, and in those with various stages of kidney disease. Finally, since 320 we set our reference standard cut-off at the lower end of the dehydration continuum to reflect impending, or 321 pre-clinical dehydration 10;12;22 , the measurement of saliva osmolality may have practical utility in identifying 322 those individuals with modest dehydration, so that further biochemistry analysis can confirm the presence of, 323
and type of dehydration, in order that specific, tailored rehydration is commenced to prevent the patient 324 developing more severe dehydration along with its associated co-morbidities and poorer outcome. 325
326
There are a few limitations of saliva that we must acknowledge. Firstly, in the current study, the requirement 327 of 25 µl of saliva sample for analysis meant that only 75% of the samples could be analyzed (although a 328 measurable quantity of saliva was collected from 97% of participants compared with only 65% of 329 participants able to provide a urine sample). However, point of care devices that utilize nano-technology for 330 the assessment of saliva osmolality are under development 40;41 . For example, the osmolarity of tears can 331 now be assessed using the principle of impedance on as little as 50nl 42;43 . Thus, this limitation should not be 332 seen to detract from the future application of saliva osmolality to assess hydration status in clinical care. 333 Secondly, with saliva sampling in a clinical population, there may be a potential confounding effect of 334 anything which can affect saliva flow rate, e.g. anticholinergic medications, or recent food/fluid consumption 335 44;45 . This is potentially important since a decrease in saliva flow explained in part, the increase in saliva 336 osmolality observed during acute dehydration in young healthy males [24] [25] [26] . However, we observed only a 337 small association between saliva flow rate and osmolality (r = -0.40), suggesting that in the current study, 338 saliva osmolality was largely independent of saliva flow rate. The physiological mechanisms responsible for 339 an increase in saliva osmolality during dehydration are unclear, but may be due to an increase in water 340 absorption in the saliva gland and/or neural factors [24] [25] [26] . Finally, although we excluded only 2 participants 341 with swallowing problems, further research should investigate the diagnostic utility of saliva indices in 342 patients with this, and other oral-related problems (e.g. oral trauma, recent dental surgery, salivary gland 343 tumors etc). 344
345
CONCLUSIONS 346
In conclusion, with the exception of low systolic blood pressure, which could aid in the specific diagnosis of 347 water-and-solute-loss dehydration, physical signs and urine markers show little utility to determine if an 348 elderly patient is dehydrated. Saliva osmolality demonstrated superior diagnostic accuracy compared with 349 physical signs and urine markers for the assessment of both water-loss and water-and-solute-loss 350 dehydration. It is particularly noteworthy that saliva osmolality was able to detect water-and-solute-loss 351 dehydration, for which a measurement of plasma osmolality would have no diagnostic utility. The 352 measurement of saliva osmolality has potential utility as a screening method to aid the diagnosis of
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3) "participants with a history of renal disease (n = 24), or who were in cardiac failure (n = 1) were excluded from data analysis." Please specify the criteria for renal disease and cardiac failure. What level of renal disease (stage?) or creatinine or other. For CHF, only "history"
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or other criteria? As you point out, the presence of renal disease, starvation, malnutrition (among others) limit the usefulness of the BUN/Cr ratio. It would be useful to discuss the level of renal disease that you excluded.
We were able to collect a quantity of saliva in 126/130 patients (97%)-reported on lines 210 and 328, although as we have stated (lines 213, 327) we only had adequate saliva (at least 25ul) to assess osmolality using our osmometer in 75% of samples. However, we have addressed this limitation in the discussion, (line 327-333) where we say that micro osmometers are in development that can assess osmolality on nano-gram quantities. We hope you feel that this is adequately addressed in the manuscript. Thanks.
